Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

3.990 +0.070 (+1.79%)
Streaming Delayed Price Updated: 9:51 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 135,124
Open 3.980
Bid (Size) 3.960 (200)
Ask (Size) 3.990 (100)
Prev. Close 3.920
Today's Range 3.940 - 4.060
52wk Range 2.860 - 13.99
Shares Outstanding 89,348,107
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Anavex (AVXL) Q1 2026 Earnings Call Transcript ↗
Anavex (AVXL) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) Reports Q1 2026 Earnings Beat, Stock Gains in Pre-Market ↗
Via Chartmill
Topics Earnings

Performance

YTD
+8.4%
+8.4%
1 Month
-14.0%
-14.0%
3 Month
-29.9%
-29.9%
6 Month
-60.5%
-60.5%
1 Year
-54.1%
-54.1%

More News

Read More
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. – AVXL
From Pomerantz LLP
Via GlobeNewswire
AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee ↗
Via Stocktwits
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
From Pomerantz LLP
Via GlobeNewswire
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential ↗
Via Stocktwits
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Anavex (AVXL) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Anavex Life Sciences Corp (NASDAQ:AVXL) Surges on Better-Than-Expected Q4 2025 Earnings ↗
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
From Pomerantz LLP
Via GlobeNewswire
News headline image
Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign' ↗
Via Stocktwits
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
AVXL Shares Slump Pre-market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug ↗
Via Stocktwits
News headline image
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug? ↗
Via Stocktwits
News headline image
Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group ↗
Via Benzinga

Frequently Asked Questions

Is Anavex Life Sciences Corp. - Common Stock publicly traded?
Yes, Anavex Life Sciences Corp. - Common Stock is publicly traded.
What exchange does Anavex Life Sciences Corp. - Common Stock trade on?
Anavex Life Sciences Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anavex Life Sciences Corp. - Common Stock?
The ticker symbol for Anavex Life Sciences Corp. - Common Stock is AVXL on the Nasdaq Stock Market
What is the current price of Anavex Life Sciences Corp. - Common Stock?
The current price of Anavex Life Sciences Corp. - Common Stock is 3.990
When was Anavex Life Sciences Corp. - Common Stock last traded?
The last trade of Anavex Life Sciences Corp. - Common Stock was at 02/13/26 09:51 AM ET
What is the market capitalization of Anavex Life Sciences Corp. - Common Stock?
The market capitalization of Anavex Life Sciences Corp. - Common Stock is 356.50M
How many shares of Anavex Life Sciences Corp. - Common Stock are outstanding?
Anavex Life Sciences Corp. - Common Stock has 356M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.